Oligonucleotide Stability Study
Oligonucleotide therapeutics can undergo chemical and physical changes during manufacturing, storage, transportation, and administration. Factors such as temperature, pH, moisture, light, oxidation, formulation composition, and container closure can influence oligonucleotide integrity and may lead to degradation, impurity formation, or changes in product quality.
Protheragen provides comprehensive Oligonucleotide Stability Study services to evaluate the stability of oligonucleotide drug substances and drug products under defined storage and stress conditions. Stability programs can support formulation development, packaging selection, shelf-life assessment, manufacturing changes, and regulatory development throughout the oligonucleotide product lifecycle.
Overview of Oligonucleotide Stability Study
Oligonucleotide stability studies are designed to monitor changes in the quality and integrity of oligonucleotide drug substances and drug products over time. Because oligonucleotides are susceptible to sequence- and chemistry-dependent degradation pathways, stability evaluation generally requires monitoring both the intended full-length product and potential degradation or related species.
Stability-indicating analytical methods can be used to evaluate changes in identity, purity, assay, molecular integrity, related substances, degradation products, and relevant physicochemical attributes. Studies may be performed under long-term, accelerated, intermediate, stress, photostability, freeze-thaw, and in-use conditions according to the development stage and intended storage conditions.
A scientifically designed stability program helps establish appropriate storage conditions, identify degradation pathways, evaluate formulation and container closure compatibility, and generate data supporting the proposed shelf life of oligonucleotide products.
Our Services
Comprehensive stability programs can be tailored to the molecular characteristics, formulation, packaging configuration, and development stage of each oligonucleotide product.
Long-Term Stability Studies
Long-term studies evaluate oligonucleotide quality under proposed storage conditions over an extended period. Testing can monitor changes in purity, assay, degradation profile, and other relevant quality attributes to support shelf-life determination.
Accelerated & Intermediate Stability Studies
Accelerated and intermediate conditions are used to assess product behavior under elevated temperature and other defined conditions. These studies can help identify potential degradation trends and support formulation and storage-condition development.
Forced Degradation Studies
Forced degradation exposes oligonucleotide materials to controlled stress conditions to investigate potential degradation pathways and generate degradation products. Results can support the development and assessment of stability-indicating analytical methods.
Photostability Studies
Photostability studies evaluate the potential effects of controlled light exposure on oligonucleotide drug substances and drug products. The resulting data can support evaluation of light sensitivity and appropriate packaging or handling requirements.
Freeze-Thaw Stability Studies
Freeze-thaw studies assess the effects of repeated freezing and thawing on oligonucleotide quality. These studies can be particularly relevant for products stored or transported under frozen conditions or formulations requiring temperature-controlled handling.
In-Use & Dilution Stability
In-use stability studies evaluate product quality after opening, dilution, preparation, or other representative handling procedures. They can support the establishment of appropriate in-use periods and administration conditions.
Formulation & Container Closure Stability
Stability studies can be used to evaluate the compatibility of oligonucleotide formulations with selected container closure systems. Potential interactions between the formulation and packaging components can be assessed as part of an integrated stability strategy.
Stability Studies After Manufacturing Changes
Stability programs can support the evaluation of changes in synthesis, purification, scale-up, formulation, manufacturing process, or packaging. Comparative stability data can help assess whether changes influence the quality and stability profile of the oligonucleotide product.
Stability Study Conditions
Depending on the development stage and study objective, stability programs may include multiple environmental and handling conditions.
| Study Type |
Primary Purpose |
| Long-Term Stability |
Establish stability under proposed storage conditions |
| Accelerated Stability |
Evaluate degradation trends under elevated conditions |
| Intermediate Stability |
Investigate stability under intermediate conditions |
| Forced Degradation |
Identify degradation pathways and degradation products |
| Photostability |
Assess sensitivity to light exposure |
| Freeze-Thaw Stability |
Evaluate effects of repeated freezing and thawing |
| In-Use Stability |
Assess product quality during intended use |
| Dilution Stability |
Evaluate stability following dilution or preparation |
| Transport Stability |
Assess product robustness during shipping and handling |
Stability Testing for Different Oligonucleotide Formats
Stability requirements can vary significantly depending on the dosage form and formulation strategy.
Oligonucleotide Drug Substance
Stability studies for drug substance can focus on:
- Identity
- Assay
- Purity
- Related substances
- Degradation products
- Molecular integrity
- Residual impurities
- Physical properties
Aqueous Oligonucleotide Injections
For aqueous injectable products, stability evaluation may additionally consider:
- Solution appearance
- pH
- Osmolality
- Particulate matter
- Aggregation
- Container closure compatibility
- Sterility-related attributes
- In-use stability
Lyophilized Oligonucleotide Products
For lyophilized formulations, studies may evaluate:
- Appearance
- Reconstitution characteristics
- Moisture
- Reconstituted solution properties
- Assay
- Purity
- Degradation products
- Container closure integrity
LNP-Formulated Oligonucleotides
For lipid nanoparticle formulations, stability programs may additionally assess:
- Particle size
- Polydispersity
- Encapsulation efficiency
- RNA/oligonucleotide integrity
- Lipid-related attributes
- Physical stability
- Aggregation
Stability-Indicating Method Development
Stability studies require analytical methods that can detect meaningful changes in product quality throughout storage.
Method development includes:
- Chromatographic Separation
Development of chromatographic methods capable of resolving the intact oligonucleotide from truncated sequences, modified species, and degradation products.
- Mass Spectrometric Characterization
Mass spectrometry can support molecular mass determination and structural characterization of degradation products or related species.
- Degradation Product Identification
Potential degradation products can be investigated using complementary analytical approaches to understand their formation and structural characteristics.
- Method Specificity Assessment
Analytical methods can be assessed for their ability to distinguish the intact oligonucleotide from degradation-related species.
Why Choose Protheragen
- Oligonucleotide-Specific Stability Strategies
Stability programs can be designed around the sequence, backbone chemistry, modifications, formulation, and packaging characteristics of each oligonucleotide.
- Integrated Analytical Support
Stability studies can be supported by complementary analytical methods for identity, purity, assay, related substances, molecular mass, and degradation-product characterization.
- Multiple Stability Conditions
Programs can incorporate long-term, accelerated, forced degradation, photostability, freeze-thaw, in-use, and other relevant conditions.
- Drug Substance & Drug Product Support
Stability evaluation can cover oligonucleotide drug substances, aqueous injections, lyophilized formulations, and other oligonucleotide drug product formats.
- Development-to-Commercial Support
Stability studies can support early formulation development, clinical-stage manufacturing, process changes, scale-up, shelf-life assessment, and commercial development.
Stability activities can be coordinated with analytical development, impurity research, formulation development, process development, and manufacturing to support an integrated CMC program.
Protheragen provides specialized stability study services for oligonucleotide drug substances and drug products, supporting the evaluation of degradation pathways, formulation stability, packaging compatibility, storage conditions, and product shelf life. Contact us to discuss your oligonucleotide stability requirements and develop a stability program tailored to your molecule, formulation, packaging configuration, and development stage.
